Healthcare provider profile · identity verified

Brian M Curtis, M.D.

Internal Medicine · CORVALLIS, OR · NPI 1245289115

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	592	175
Levothyroxine Sodium	Levothyroxine Sodium	572	155
Losartan Potassium	Losartan Potassium	529	166
Rosuvastatin Calcium	Rosuvastatin Calcium	351	94
Lisinopril	Lisinopril	326	90
Metoprolol Succinate	Metoprolol Succinate	314	103
Metformin Hcl	Metformin Hcl	313	89
Amlodipine Besylate	Amlodipine Besylate	284	101
Eliquis	Apixaban	273	59
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	264	50
Simvastatin	Simvastatin	215	62
Omeprazole	Omeprazole	199	59
Gabapentin	Gabapentin	175	50
Potassium Chloride	Potassium Chloride	169	51
Tamsulosin Hcl	Tamsulosin Hcl	152	48
Furosemide	Furosemide	150	49
Zolpidem Tartrate	Zolpidem Tartrate	145	38
Hydrochlorothiazide	Hydrochlorothiazide	140	41
Carvedilol	Carvedilol	139	39
Pantoprazole Sodium	Pantoprazole Sodium	131	38
Alprazolam	Alprazolam	114	24
Lorazepam	Lorazepam	112	33
Allopurinol	Allopurinol	111	31
Alendronate Sodium	Alendronate Sodium	107	34
Escitalopram Oxalate	Escitalopram Oxalate	106	26
Metformin Hcl Er	Metformin Hcl	102	33
Pravastatin Sodium	Pravastatin Sodium	95	28
Metoprolol Tartrate	Metoprolol Tartrate	94	34
Tramadol Hcl	Tramadol Hcl	93	20
Oxycodone Hcl	Oxycodone Hcl	92	22
Trazodone Hcl	Trazodone Hcl	91	21
Atenolol	Atenolol	84	23
Bupropion Xl	Bupropion Hcl	84	22
Olmesartan Medoxomil	Olmesartan Medoxomil	75	21
Warfarin Sodium	Warfarin Sodium	73	19
Albuterol Sulfate Hfa	Albuterol Sulfate	68	23
Synthroid	Levothyroxine Sodium	68	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	68	18
Jardiance	Empagliflozin	67	20
Clopidogrel	Clopidogrel Bisulfate	63	20
Duloxetine Hcl	Duloxetine Hcl	59	14
Sertraline Hcl	Sertraline Hcl	57	17
Famotidine	Famotidine	52	13
Irbesartan	Irbesartan	49	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	13
Mirtazapine	Mirtazapine	46	suppressed
Ozempic	Semaglutide	46	13
Montelukast Sodium	Montelukast Sodium	44	14
Paroxetine Hcl	Paroxetine Hcl	43	suppressed
Spironolactone	Spironolactone	43	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	14
Tizanidine Hcl	Tizanidine Hcl	40	12
Lovastatin	Lovastatin	39	14
Fluticasone Propionate	Fluticasone Propionate	38	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	12
Citalopram Hbr	Citalopram Hydrobromide	37	15
Glimepiride	Glimepiride	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Pregabalin	Pregabalin	35	12
Lansoprazole	Lansoprazole	33	suppressed
Mounjaro	Tirzepatide	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Fenofibrate	Fenofibrate	32	11
Labetalol Hcl	Labetalol Hcl	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Testosterone	Testosterone	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	19
Cephalexin	Cephalexin	30	14
Finasteride	Finasteride	30	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Acyclovir	Acyclovir	27	16
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	25
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	22
Propranolol Hcl	Propranolol Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Prednisone	Prednisone	22	11
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Naproxen	Naproxen	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Diazepam	Diazepam	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Baclofen	Baclofen	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Estradiol	Estradiol	18	11
Vascepa	Icosapent Ethyl	18	suppressed
Colchicine	Colchicine	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Ondansetron Odt	Ondansetron	17	11
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Zaleplon	Zaleplon	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Lactulose	Lactulose	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Torsemide	Torsemide	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Febuxostat	Febuxostat	11	suppressed
Glipizide	Glipizide	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error